A new study led by Art Sedrakyan, MD, of Weill Cornell Medical College in New York City, recently found that new metal-on-metal and ceramic-on-ceramic hip implants have no better outcomes than traditional polyethylene implants, according to a Weill Cornell news release.
The FDA-funded data analysis found no clear advantage of one type of hip implant over another for effectiveness and reported a potential for harm using metal-on-metal implants. The paper examines 3,139 patients enrolled in 18 comparative studies and more than 830,000 surgeries reported in national registries.
The authors found that while a single trial showed fewer revisions for ceramic-on-ceramic implants, as compared with metal-on-polyethylene implants, national registry data did not support the finding.
An article based on the analysis will be published in the Dec. 1 edition of the journal BMJ.
Related Articles on Orthopedic Implants:
Global Implant Market to Reach $46.5B by 2017
21 Spine Devices Receive FDA 510(k) Clearance in October
Hospital for Special Surgery Receives $1M Grant for Mary and Fred Trump Institute for Implant Analysis
The authors found that while a single trial showed fewer revisions for ceramic-on-ceramic implants, as compared with metal-on-polyethylene implants, national registry data did not support the finding.
An article based on the analysis will be published in the Dec. 1 edition of the journal BMJ.
Related Articles on Orthopedic Implants:
Global Implant Market to Reach $46.5B by 2017
21 Spine Devices Receive FDA 510(k) Clearance in October
Hospital for Special Surgery Receives $1M Grant for Mary and Fred Trump Institute for Implant Analysis